Antag Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$84.1M

Antag Therapeutics is a biopharmaceutical company developing treatments for obesity and cardiometabolic diseases, focusing on injectable therapies like their novel GIPR antagonist, AT-7687.